These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36109762)

  • 41. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
    Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
    Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy.
    Hong C; Wang A; Xia J; Liang J; Zhu Y; Wang D; Zhan H; Feng C; Jiang X; Pan J; Wang J
    Int J Nanomedicine; 2024; 19():2879-2888. PubMed ID: 38525007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy.
    Zhang H; Chen L; Zhao Y; Luo N; Shi J; Xu S; Ma L; Wang M; Gu M; Mu C; Xiong Y
    Asian J Pharm Sci; 2023 Mar; 18(2):100796. PubMed ID: 37008735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer.
    Zheng S; Zou Y; Tang Y; Yang A; Liang JY; Wu L; Tian W; Xiao W; Xie X; Yang L; Xie J; Wei W; Xie X
    Oncoimmunology; 2022; 11(1):2020984. PubMed ID: 35003899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophage derived Exosomal Docetaxel (Exo-DTX) for pro-metastasis suppression: QbD driven formulation development, validation, in-vitro and pharmacokinetic investigation.
    Basak M; Narisepalli S; Salunkhe SA; Tiwari S; Chitkara D; Mittal A
    Eur J Pharm Biopharm; 2024 Feb; 195():114175. PubMed ID: 38185191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antitumor Effects of Docetaxel in Truncated Basic Fibroblast Growth Factor- Functionalized Liposomes Delivered by d-α-tocopheryl Polyethylene Glycol 2000 Succinate.
    Wen J; Wang Z; Qiu N; Liu H; Shu X; Zhu Z; Bai P; Yang L; Chen L
    Curr Pharm Des; 2020; 26(34):4338-4348. PubMed ID: 32324508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Docetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicity.
    Pereira S; Egbu R; Jannati G; Al-Jamal WT
    Int J Pharm; 2016 Nov; 514(1):150-159. PubMed ID: 27863659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection of Skin Fibroblasts from Infrared-A-Induced Photo-Damage Using Ginsenoside Rg3(S)-Incorporated Soybean Lecithin Liposomes.
    Jung WH; Song J; You G; Lee JH; Lee SW; Ahn JH; Mok H
    J Microbiol Biotechnol; 2023 Jan; 33(1):135-141. PubMed ID: 36575857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes.
    Kushwah V; Jain DK; Agrawal AK; Jain S
    Colloids Surf B Biointerfaces; 2018 Dec; 172():213-223. PubMed ID: 30172202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma.
    Wang B; Xu Q; Zhou C; Lin Y
    Acta Biochim Pol; 2021 Nov; 68(4):711-715. PubMed ID: 34730903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic Targeting of Stromal-Tumor HGF-MET Signaling in an Organotypic Triple-Negative Breast Tumor Model.
    Singh S; Lamichhane A; Rafsanjani Nejad P; Heiss J; Baumann H; Gudneppanavar R; Leipzig ND; Konopka M; Luker GD; Tavana H
    Mol Cancer Res; 2022 Jul; 20(7):1166-1177. PubMed ID: 35348758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In Vitro Evaluation of NLS-DTX Activity in Triple-Negative Breast Cancer.
    Paiva KLR; Radicchi MA; Báo SN
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
    Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
    Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ginsenoside Rg3 Reduces Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β1 by Inactivation of AKT in HMrSV5 Peritoneal Mesothelial Cells.
    Yan X; Zhang W; Kong F; Li Q; Shan W; Zhang C; Han T; Che Y; Zhang Y
    Med Sci Monit; 2019 Sep; 25():6972-6979. PubMed ID: 31527568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer.
    Zuo S; Wang J; An X; Wang Z; Zheng X; Zhang Y
    Front Bioeng Biotechnol; 2022; 10():945472. PubMed ID: 36032706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix Metalloproteinase-2-Responsive Surface-Changeable Liposomes Decorated by Multifunctional Peptides to Overcome the Drug Resistance of Triple-Negative Breast Cancer through Enhanced Targeting and Penetrability.
    Liu C; Zhao Z; Gao R; Zhang X; Sun Y; Wu J; Liu J; Chen C
    ACS Biomater Sci Eng; 2022 Jul; 8(7):2979-2994. PubMed ID: 35666956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages.
    Chen M; Miao Y; Qian K; Zhou X; Guo L; Qiu Y; Wang R; Gan Y; Zhang X
    Nano Lett; 2021 Jul; 21(14):6031-6041. PubMed ID: 34240603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment.
    Zhang P; Qin C; Liu N; Zhou X; Chu X; Lv F; Gu Y; Yin L; Liu J; Zhou J; Huo M
    Biomaterials; 2022 May; 284():121518. PubMed ID: 35462305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells.
    Eloy JO; Ruiz A; de Lima FT; Petrilli R; Raspantini G; Nogueira KAB; Santos E; de Oliveira CS; Borges JC; Marchetti JM; Al-Jamal WT; Chorilli M
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111185. PubMed ID: 32574928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.